92 related articles for article (PubMed ID: 20060456)
1. Pharmacokinetics analysis of sustained release hGH biodegradable implantable tablets using a mouse model of human ovarian cancer.
Santoveña A; Fariña JB; Llabrés M; Zhu Y; Dannies P
Int J Pharm; 2010 Mar; 388(1-2):175-80. PubMed ID: 20060456
[TBL] [Abstract][Full Text] [Related]
2. Controlled release of bioactive recombinant human growth hormone from PLGA microparticles.
Rafi M; Singh SM; Kanchan V; Anish CK; Panda AK
J Microencapsul; 2010; 27(6):552-60. PubMed ID: 20690791
[TBL] [Abstract][Full Text] [Related]
3. Biodegradable polymeric microspheres with "open/closed" pores for sustained release of human growth hormone.
Kim HK; Chung HJ; Park TG
J Control Release; 2006 May; 112(2):167-74. PubMed ID: 16542746
[TBL] [Abstract][Full Text] [Related]
4. Rescue of SCID murine ischemic hindlimbs with pH-modified rhbFGF/poly(DL-lactic-co-glycolic acid) implants.
Zhong Y; Zhang L; Ding AG; Shenderova A; Zhu G; Pei P; Chen RR; Mallery SR; Mooney DJ; Schwendeman SP
J Control Release; 2007 Oct; 122(3):331-7. PubMed ID: 17706831
[TBL] [Abstract][Full Text] [Related]
5. Sustained release hGH microsphere formulation produced by a novel supercritical fluid technology: in vivo studies.
Jordan F; Naylor A; Kelly CA; Howdle SM; Lewis A; Illum L
J Control Release; 2010 Jan; 141(2):153-60. PubMed ID: 19772878
[TBL] [Abstract][Full Text] [Related]
6. A new animal model for evaluation of long-term growth rate over one month by rhGH/PLGA microcapsule formulations.
Takada S; Kurokawa T; Misaki M; Taira K; Yamagata Y
J Pharm Pharmacol; 2003 Jul; 55(7):951-61. PubMed ID: 12906752
[TBL] [Abstract][Full Text] [Related]
7. Sustained delivery of human growth hormone using a polyelectrolyte complex-loaded thermosensitive polyphosphazene hydrogel.
Park MR; Chun C; Ahn SW; Ki MH; Cho CS; Song SC
J Control Release; 2010 Nov; 147(3):359-67. PubMed ID: 20713099
[TBL] [Abstract][Full Text] [Related]
8. Development of implant tablet for a week-long sustained release.
Takahashi M; Onishi H; Machida Y
J Control Release; 2004 Nov; 100(1):63-74. PubMed ID: 15491811
[TBL] [Abstract][Full Text] [Related]
9. Sustained delivery of IL-1 Ra from biodegradable microspheres reduces the number of murine B16 melanoma lung metastases.
Lavi G; Voronov E; Dinarello CA; Apte RN; Cohen S
J Control Release; 2007 Nov; 123(2):123-30. PubMed ID: 17900737
[TBL] [Abstract][Full Text] [Related]
10. Paclitaxel releasing films consisting of poly(vinyl alcohol)-graft-poly(lactide-co-glycolide) and their potential as biodegradable stent coatings.
Westedt U; Wittmar M; Hellwig M; Hanefeld P; Greiner A; Schaper AK; Kissel T
J Control Release; 2006 Mar; 111(1-2):235-46. PubMed ID: 16466824
[TBL] [Abstract][Full Text] [Related]
11. Development of a novel sustained release formulation of recombinant human growth hormone using sodium hyaluronate microparticles.
Kim SJ; Hahn SK; Kim MJ; Kim DH; Lee YP
J Control Release; 2005 May; 104(2):323-35. PubMed ID: 15907583
[TBL] [Abstract][Full Text] [Related]
12. A mathematical model for interpreting in vitro rhGH release from laminar implants.
Santoveña A; García JT; Oliva A; Llabrés M; Fariña JB
Int J Pharm; 2006 Feb; 309(1-2):38-43. PubMed ID: 16376037
[TBL] [Abstract][Full Text] [Related]
13. Development of a single-dose stabilized poly(D,L-lactic-co-glycolic acid) microspheres-based vaccine against hepatitis B.
Jaganathan KS; Singh P; Prabakaran D; Mishra V; Vyas SP
J Pharm Pharmacol; 2004 Oct; 56(10):1243-50. PubMed ID: 15482638
[TBL] [Abstract][Full Text] [Related]
14. Bupivacaine-loaded biodegradable poly(lactic-co-glycolic) acid microspheres I. Optimization of the drug incorporation into the polymer matrix and modelling of drug release.
Zhang H; Lu Y; Zhang G; Gao S; Sun D; Zhong Y
Int J Pharm; 2008 Mar; 351(1-2):244-9. PubMed ID: 18024022
[TBL] [Abstract][Full Text] [Related]
15. Novel biocompatible intraperitoneal drug delivery system increases tolerability and therapeutic efficacy of paclitaxel in a human ovarian cancer xenograft model.
Vassileva V; Grant J; De Souza R; Allen C; Piquette-Miller M
Cancer Chemother Pharmacol; 2007 Nov; 60(6):907-14. PubMed ID: 17375303
[TBL] [Abstract][Full Text] [Related]
16. Cationic and thermosensitive protamine conjugated gels for enhancing sustained human growth hormone delivery.
Park MR; Chun C; Ahn SW; Ki MH; Cho CS; Song SC
Biomaterials; 2010 Feb; 31(6):1349-59. PubMed ID: 19879647
[TBL] [Abstract][Full Text] [Related]
17. Long-term human growth hormone expression and partial phenotypic correction by plasmid-based gene therapy in an animal model of isolated growth hormone deficiency.
Oliveira NA; Cecchi CR; Higuti E; Oliveira JE; Jensen TG; Bartolini P; Peroni CN
J Gene Med; 2010 Jul; 12(7):580-5. PubMed ID: 20603861
[TBL] [Abstract][Full Text] [Related]
18. [Establishment and comparison of two intraperitoneally transplanted human ovarian carcinoma models with immune reconstitution in severe combined immunodeficient mice].
Li Y; Cui H; Chang XH; Feng J; Fu TY; Feng YJ; Wei LH
Ai Zheng; 2004 Feb; 23(2):160-4. PubMed ID: 14960235
[TBL] [Abstract][Full Text] [Related]
19. Optimized bone regeneration based on sustained release from three-dimensional fibrous PLGA/HAp composite scaffolds loaded with BMP-2.
Fu YC; Nie H; Ho ML; Wang CK; Wang CH
Biotechnol Bioeng; 2008 Mar; 99(4):996-1006. PubMed ID: 17879301
[TBL] [Abstract][Full Text] [Related]
20. Characterization of porous poly(D,L-lactic-co-glycolic acid) sponges fabricated by supercritical CO2 gas-foaming method as a scaffold for three-dimensional growth of Hep3B cells.
Zhu XH; Lee LY; Jackson JS; Tong YW; Wang CH
Biotechnol Bioeng; 2008 Aug; 100(5):998-1009. PubMed ID: 18551526
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
